Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1595)
Reports (56)
SAGE documentation (225)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (275)
Americas (766)
Eastern Mediterranean (50)
Europe (707)
South-East Asia (81)
Western Pacific (200)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (69)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (131)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (50)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
4872 results found
2025
∙
ATAGI
ATAGI statement on the administration of COVID-19 vaccines in 2025
2025
∙
ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2025
2025
∙
Folkhälsomyndigheten
Vaccination against mpox – a second update of vaccine recommendations due to increased spread of mpox clade 1
2025
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against Yellow Fever in Belgium
2025
∙
NACI
Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024
2025
∙
CAVEI
CAVEI recommendation on annual vaccination against COVID-19 for the year 2025
2025
∙
NACI
Guidance on the use of COVID-19 vaccines for 2025 to summer 2026
2025
∙
Global NITAG Network
Standard Operating Procedures of the Global NITAG Network
2024
∙
Nangsue, C. Srisurapanont, K. Sudjaritruk, T.
A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis
2024
∙
Ewongwo, A. Sahor, A. F. Ngwa, W. Nwachukwu, C.
A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register